Summary
Both the MAO-B inhibitor deprenyl (2.5–10 mg/kg, ip, 60 min prior) and the MAO-B substrate β-phenylethylamine (PEA, 40 μg, icv) potentiated the analgesic action of the enkephalinase inhibitor phosphoramidon (250 μg, icv) in animals allowed normal sleep. The enhancing effect of PEA on phosphoramidon analgesia was further potentiated by deprenyl (5 mg/kg, ip) pretreatment. Deprenyl (5 mg/kg, ip) or PEA (40 μg, iv) given alone did not induce analgesia in animals allowed undisturbed sleep.
REM sleep deprivation (REMSD) decreased the basal pain threshold and abolished the analgesic effect of phosphoramidon. The administration of deprenyl and/or PEA failed to restore the analgesic effect of phosphoramidon in REM sleep deprived animals.
The results indicate that excess PEA has a stimulatory effect on the analgesic activity of endogenously released enkephalins in rats allowed undisturbed sleep but not in REM sleep deprived animals.
It is suggested that the failure of phosphoramidon to induce analgesia after REMSD, is probably due to a functional insufficiency of an enkephalinergic system.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Basbaum AI, Fields HL (1984) Endogenous pain control systems: brain spinal patways and endorphin circuitry. Ann Rev Neurosci 7:309–338
Benedetti MS, Keane PE (1980) Differential changes in monoamine oxidase A and B activity in the aging rat brain. J Neurochem 35:1026–1032
Boden R, Botting R, Coulson P, Spanswick G (1984) Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice. Br J Pharmacol 82:151–154
Chaillet P, Coulaud A, Fournie-Zaluski MC, Gacel G, Roques BP, Costentin J (1983) Pain control by endogenous enkephalins is mediated by mu opioid receptors. Life Sci 33:685–688
Davis GC, Buchsbaum MS, Bunney WE (1979) Analgesia to painful stimuli in affective illness. Am J Psychiatr 136:1148–1151
Dourish CT, Cooper SJ (1984) Potentiation of total horizontal activity and ambulation in rats treated with combinations of β-phenylethylamine and naloxone. Neuropharmacology 23: 1059–1064
Fuentes JA, Garzon J, Del Rio J (1977) Potentiation of morphine analgesia in mice after inhibition of brain type-B monoamine oxidase. Neuropharmacology 16:857–862
Garzon J, Moratalla R, Del Rio J (1980) Potentiation of the analgesia induced in rats by morphine or [d-Ala2]-metenkephalinamide after inhibition of brain type B monoamine oxidase: the role of phenylethylamine. Neuropharmacology 19:723–729
Garrick NA, Murphy DL (1980) Species differences in the deamination of dopamine and other substrates for monoamine oxidase in the brain. Psychopharmacology 72:27–33
Hicks RA, Coleman DD, Ferrante F, Sahatjian M, Hawkins J (1979) Pain thresholds in rate during recovery from REM sleep deprivation. Percept Mot Skills 48:687–690
Hudgin RL, Charleson SE, Zimmerman M, Mumford R, Wood PL (1981) Enkephalinase: selective peptide inhibitors. Life Sci 29:2593–2601
Iwamoto ET, Ho IK (1972) The effects of MAO inhibition on morphine analgesia in mice. Fed Proc 31:504
Jounela AJ, Mattila MJ, Knoll J (1977) Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits. Biochem Pharmacol 26:806–808
Kubota K, Matsuoka Y, Sakuma M, Satoh S, Uruno T, Sunagane N (1982) Characteristic of analgesia induced by noncatecholic phenylethylamines in mice. Life Sci 31:1221–1224
Mann J, Gershon S (1980) l-Deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression. Life Sci 26:877–882
Mendelson WB, Guthrie RD, Frederick G, Wyatt RJ (1974) The flower pot technique of rapid eye movement (REM) sleep deprivation. Pharmacol Biochem Behav 2:553–556
Pickar D, Cohen MR, Naber D, Cohen RM (1982) Clinical studies of the endogenous opioid system. Biol Psychiatr 17:1243–1276
Randall OL, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn 111:409–419
Risch S (1982) β-Endorphin hypersecretion in depression: possible cholinergic mechanisms. Biol Psychiatr 17:1071–1079
Rupreht J, Ukponmwan OE, Admiraal PV, Dzoljic MR (1983) Effect of phosphoramidon — a selective enkephalinase inhibitor — on nociception and behaviour. Neurosci Letts 41:331–335
Saxena PR (1985) An interactive computer programme for data management and parametric and non-parametric statistical analysis. Proc Br Pharmacol Soc Edinburgh Abstr D3
Steel RGD, Torrie JH (1980) Principles and procedures of statistics, biometrical approach, McGraw-Hill Kogakusha Ltd, Tokyo
Taylor DC (1962) Alarming reaction to pethidine in patients on phenelzine. Lancet ii 401–402
Ukponmwan OE, Poel-Heisterkamp AL van den, Haffmans J, Dzoljic MR (1983) MAO-B inhibitor deprenyl and β-phenylethylamine potentiate [d-Ala2]-met-enkephalinamide-induced seizures. Naunyn-Schmiedeberg's Arch Pharmacol 322:38–41
Ukponmwan OE, Rupreht J, Dzoljic MR (1984a) REM sleep deprivation decreases the antinociceptive property of enkephalinase inhibition, morphine and cold-water stress. Gen Pharmacol 15:255–258
Ukponmwan OE, Dzoljic MR (1984b) Enkephalinase inhibition antagonizes the increased susceptibility to seizure induced by REM sleep deprivation. Psychopharmacology 83:229–232
Ukponmwan OE, Poel-Heisterkamp AL van den, Dzoljic MR (1985) REM sleep deprivation decreases the grooming and shaking behaviour induced by enkephalinase inhibitor or opiate withdrawal. Pharmacol Biochem Behav 23:385–389
Vogel GW, Vogel F, McAbee RS, Thurmond AJ (1980) Improvement of depression by REM sleep deprivation. Arch Gen Psychiat 37:247–253
Wolf ME, Mosnaim AD (1983) Phenylethylamine in neuropsychiatric disorders. Gen Pharmacol 14:385–390
Wu PH, Boulton AA (1975) Metabolism, distribution and disappearance of injected β-phenylethylamine in the rat. Can J Biochem 53:42–50
Yang H-YT, Neff NH (1974) The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J Pharmacol Exp Ther 189:733–740
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ukponmwan, O.E., Rupreht, J. & Dzoljic, M. An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 376–379 (1986). https://doi.org/10.1007/BF00500090
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00500090